[1]
2020. Potential pharmacological approach in the regulation of angiotensin-II conversion enzyme and dipeptidyl-peptidase 4 in diabetic COVID-19 patients. Italian Journal of Medicine. 15, 1 (Dec. 2020). DOI:https://doi.org/10.4081/itjm.2020.1435.